Five barriers to the commercialization of medical AI research

If we want to encourage commercialization of medical AI research from our academic medical centres, then a serious effort is needed to address barriers.

Commercializing academic research has multiple benefits, including generating beneficial economic activity within Canada that can also attract highly skilled talent from overseas, writes Khaled El Emam. Photograph courtesy of Pexels

Opinion

BY KHALED EL EMAM

March 30, 2022

Consistent and significant investments in AI research in Canada have resulted in globally recognized centres of academic excellence across the country. The often-repeated challenge moving forward is to translate that academic work into commercial success. Based on my experience spinning off two comp...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy